Related Experiment Video
Updated: Jul 25, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Intrauterine growth restriction increases morbidity and mortality among premature neonates
Thomas J Garite1, Reese Clark, James A Thorp
1The Pediatrix-Obstetrix Center for Research and Education, University of California-Irvine Medical Center, 101 The City Drive, Orange, CA 92683-1491, USA. tjgarite@uci.edu
Insights
Intrauterine growth restriction (IUGR) in premature infants is linked to higher mortality and morbidity, regardless of diagnosis timing. This highlights the need for careful obstetric counseling and neonatal care planning for affected newborns.
Area of Science:
- Neonatalogy
- Perinatology
- Obstetrics
Background:
- Intrauterine growth restriction (IUGR) is a significant factor in premature deliveries, with varied reported neonatal outcomes.
- Limited data exists on neonatal outcomes for IUGR infants across all viable gestational ages and comparisons between antenatal and neonatal diagnoses.
Purpose of the Study:
- To evaluate neonatal outcomes in infants with IUGR using a large contemporary database.
- To determine gestational age-specific associations between IUGR, morbidity, and mortality.
- To compare perinatal outcomes based on antenatal versus neonatal diagnosis of IUGR.
Main Methods:
- Utilized a database of neonatal intensive care unit (NICU) admissions from 124 NICUs (1997-2001).
- Reviewed data for singleton, inborn neonates born between 23-34 weeks gestation, excluding major congenital anomalies.
- Compared three IUGR measures (antepartum diagnosis, small for gestational age [SGA], or both) against gestational age-matched controls.
Main Results:
- The study included 29,916 neonates; 4.8% had IUGR, 9.8% were SGA, and 12.3% had at least one marker.
- IUGR markers were associated with increased mortality, necrotizing enterocolitis, respiratory support needs, and retinopathy of prematurity from 25-32 weeks gestation.
- These associations remained significant after correcting for gestational age, antenatal steroid exposure, gender, and delivery mode.
Conclusions:
- IUGR is a serious condition associated with increased morbidity and mortality in premature neonates.
- The definition of IUGR or timing of diagnosis (antenatal vs. postnatal) did not alter the increased risk.
- Findings are crucial for obstetric counseling, decision-making, and proactive management of premature infants with IUGR.
Objective:
Intrauterine growth restriction (IUGR) is an important reason for premature delivery and has been reported to be associated with increased mortality, but in some studies paradoxically, improved morbidities. Data on neonatal outcomes for infants with IUGR at each viable gestational age at birth from large numbers of deliveries are lacking. More particularly, data on perinatal outcome related to an antenatal diagnosis of IUGR compared with a neonatal diagnosis are particularly deficient. Therefore, by using a large contemporary database, we evaluated the outcomes of neonates with IUGR and the gestational age-specific associations between growth restriction, morbidity, and mortality.
Study Design:
With the use of a database formed from a computer-assisted tool that generates clinical progress notes and discharge summaries on neonatal intensive care unit (NICU) admissions, we reviewed data on neonates discharged from 124 NICUs between January 1, 1997, and December 31, 2001. We evaluated singleton, inborn neonates who delivered between 23 and 34 weeks, excluding major congenital anomalies. We compared 3 measures of IUGR: antenatally diagnosed IUGR; a birth weight below the 10th percentile (small for gestational age [SGA]), and newborn infants with either or both of these diagnoses against a control group of gestational age-matched infants meeting none of these criteria whose birth weights were no greater than the 90th percentile.
Results:
Our sample included 29,916 prematurely born neonates; 1,451 (4.8%) with IUGR, 2,936 (9.8%) who were SGA, and 3,708 (12.3%) had at least 1 of these 2 markers. There were 22,798 (76%) normally grown control neonates. Within each gestational age group from 25 to 32 weeks, each marker of IUGR was associated with increased mortality, necrotizing enterocolitis, need for respiratory support at 28 days of age, and retinopathy of the premature. When corrected for gestational age, exposure to antenatal steroids, gender, and mode of delivery, these associations remained significant.
Conclusion:
IUGR remains a serious problem that is associated with increased morbidity and mortality among prematurely born neonates, regardless of the definition used or whether the diagnosis is made antenatally or after birth. These results are important for obstetric counseling and decision making and for the anticipation and treatment of premature newborn infants.
Related Concept Videos
Teratogenicity
Intrauterine Drug Delivery Systems

